Skip to Main Content

Author Details

John R Wunderlich
National Cancer Institute
1963
134
64
PMIDPaper TitleJournal TitlePublished Year
30518633A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.Clin Cancer Res2019
30518633A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers.Clin Cancer Res2019
31164343Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.Cancer Discov2019
31164343Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.Cancer Discov2019
29853601T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.Clin Cancer Res2018
29853601T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers.Clin Cancer Res2018
28093487A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma.Clin Cancer Res2017
28377481Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer.Clin Cancer Res2017
28395880Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.Lancet Oncol2017
28093487A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma.Clin Cancer Res2017
28377481Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer.Clin Cancer Res2017
28395880Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.Lancet Oncol2017
26901407Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.Nat Med2016
27217459Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.J Clin Oncol2016
26901407Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.Nat Med2016
26712692Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.Clin Cancer Res2016
27217459Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.J Clin Oncol2016
26712692Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.Clin Cancer Res2016
25538264A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.Clin Cancer Res2015
25538264A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.Clin Cancer Res2015
25823737Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.J Clin Oncol2015
25424856Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans.Clin Cancer Res2015
26516200Immunogenicity of somatic mutations in human gastrointestinal cancers.Science2015
26516200Immunogenicity of somatic mutations in human gastrointestinal cancers.Science2015
25823737Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.J Clin Oncol2015
25424856Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans.Clin Cancer Res2015
24218514Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.Clin Cancer Res2014
24270663Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.J Invest Dermatol2014
24218514Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy.Clin Cancer Res2014
24812403Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.Science2014
24667641PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.J Clin Invest2014
24739903Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.J Invest Dermatol2014
24647571Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration.Clin Cancer Res2014
24812403Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.Science2014
24739903Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.J Invest Dermatol2014
24667641PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.J Clin Invest2014
24647571Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration.Clin Cancer Res2014
24270663Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.J Invest Dermatol2014
23650429Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.J Clin Oncol2013
23904171Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy.J Immunol2013
24021875Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.Clin Cancer Res2013
23650429Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.J Clin Oncol2013
23904171Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy.J Immunol2013
24021875Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.Clin Cancer Res2013
22576345Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.J Immunother2012
22837179Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.Clin Cancer Res2012
22576345Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.J Immunother2012
22726267Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.World J Surg Oncol2012
22726267Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.World J Surg Oncol2012
22837179Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.Clin Cancer Res2012
  • 1 - 50 of 268

Recommended Authors

Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Osnat Bohana-Kashtan
BioLineRx Ltd
Career Start Year 1999
Number of shared co-authors 2
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 3
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 12
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 4
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 5
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 1
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 0
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 2
Frances T Hakim
National Cancer Institute
Career Start Year 1984
Number of shared co-authors 5
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Helen C O'Neill
UCL Institute for Women's Health, University College London
Career Start Year 1979
Number of shared co-authors 0
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 6
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 6
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1976
Number of shared co-authors 0
Victor H Engelhard
University of Virginia School of Medicine
Career Start Year 1976
Number of shared co-authors 1
Hilary S Warren
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 3
Ellen R Richie
The University of Texas MD Anderson Cancer Center
Career Start Year 1970
Number of shared co-authors 1
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1969
Number of shared co-authors 7
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 7
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 6
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 0
Lloyd J Old
Ludwig Institute for Cancer Research
Career Start Year 1959
Number of shared co-authors 1

Collaborators

Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 68
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 19
Todd D Prickett
National Cancer Institute
Co-authored papers 8
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 4
Armando C Filie
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Co-authored papers 3
Julia C Cronin
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 3
Jimmy C Lin
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 3
Patricia Fetsch
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Neena S Agrawal
Co-authored papers 3
Xiaomu Wei
Cornell University
Co-authored papers 3
Michael I Nishimura
Co-authored papers 2
Carolyn E Banister
University of South Carolina
Co-authored papers 2
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
David M Berman
Queen's University
Co-authored papers 2
Allison S Burrell
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Phillip Buckhaults
University of South Carolina
Co-authored papers 2
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 1
Wendy Westbroek
Salish Kootenai College
Co-authored papers 1
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Co-authored papers 1
Chenwei Wang
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University
Co-authored papers 1
Paul H Duray
National Cancer Institute, National Institutes of Health
Co-authored papers 1
William J Pavan
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Stephen A Migueles
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Julie A Hong
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Release 1.2